Buy Sun Pharma Advanced Research, target price Rs 172: Jay Thakkar
Jay Thakkar recommended to keep stoploss at Rs 149.
Sun Pharma Advanced Research Company Ltd., incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 4119.39 Crore) operating in Pharmaceuticals sector.
Sun Pharma Advanced Research Company Ltd. key Products/Revenue Segments include Sale of services which contributed Rs 182.87 Crore to Sales Value (100.00 % of Total Sales)for the year ending 31-Mar-2019.
For the quarter ended 30-09-2019, the company has reported a Standalone sales of Rs 17.19 Crore, down -.75 % from last quarter Sales of Rs 17.32 Crore and down -71.98 % from last year same quarter Sales of Rs 61.35 Crore Company has reported net profit after tax of Rs -63.16 Crore in latest quarter. The company’s top management includes Dr.Ferzaan Engineer, Dr.T Rajamannar, Mr.Dilip S Shanghvi, Mr.Mark Simon, Mr.Sudhir V Valia, Ms.Bhavna Doshi. Company has S R B C & Co. LLP as its auditoRs As on 30-06-2019, the company has a total of 262,047,506 shares outstanding.